The pharmaceutical manufacturer Pfizer has partnered with a United Nations-backed nonprofit organization to provide its oral COVID-19 treatment to 95 different countries for minimal cost.

Pfizer announced Monday it signed a licensing agreement with Medicines Patent Pool to produce a pill form of its COVID-19 antiviral treatment medicine, a partnership that will allow the company to provide coronavirus treatments to lower-income countries.